India’s Biopharma Future: Insights from Biological E & BDC

Exciting moments at the India Bioprocess Design Center (BDC) in Hyderabad, where Merrilyn Datta hosted a customer interview with Mr. Veerapandu, VP of R&D at Biological E. Key highlights from the discussion: 🔹 The evolving biosimilars and biopharma landscape in India 🔹 What sets Biological E apart 🔹 Opportunities and challenges shaping India’s biopharmaceutical sector 🔹 Potential avenues for collaboration with Thermo Fisher and the BDC Moments like these reflect what our BDCs are all about—bringing together expertise, collaboration, and hands-on experience to drive meaningful outcomes, validated by the voice of our customers.